• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根除治疗后我们应如何以及何时检测幽门螺杆菌感染?

[How and when should we check Helicobacter pylori infection after eradication therapy?].

作者信息

Kawano S, Tsuji S

机构信息

Department of Clinical Laboratory Science, School of Allied Health Sciences, Faculty of Medicine Osaka University.

出版信息

Nihon Rinsho. 2001 Feb;59(2):319-22.

PMID:11218405
Abstract

In Japan, The new triple therapy was opened for Helicobacter pylori (HP) eradication from Nov. 1, 2000. The Japanese Society for Helicobacter Research presented a guideline for HP eradication. It recommended that HP infection should be checked at least 4 weeks after the treatment for peptic ulcer and HP infection using HPIgG antibody, rapid urease test, urea breath test, histology and/or culture. However, it did not state the best way and suitable timing to check HP infection after the eradication therapy. In this study, we investigated the accuracy of PyloriTek test(a 1-h rapid urease test) and tried to establish the suitable timing for checking HP infection after eradication therapy. In conclusion, when patients are examined more than 4 months after eradication therapy, the use of PyloriTek alone may be sufficient for correctly diagnosing HP infection.

摘要

在日本,新型三联疗法于2000年11月1日开始用于根除幽门螺杆菌(HP)。日本幽门螺杆菌研究学会提出了HP根除指南。该指南建议,对于消化性溃疡和HP感染患者,应在治疗后至少4周使用HP IgG抗体、快速尿素酶试验、尿素呼气试验、组织学和/或培养法检查HP感染情况。然而,该指南并未说明根除治疗后检查HP感染的最佳方法和合适时机。在本研究中,我们调查了PyloriTek试验(一种1小时快速尿素酶试验)的准确性,并试图确定根除治疗后检查HP感染的合适时机。总之,在根除治疗4个月后对患者进行检查时,单独使用PyloriTek可能足以正确诊断HP感染。

相似文献

1
[How and when should we check Helicobacter pylori infection after eradication therapy?].根除治疗后我们应如何以及何时检测幽门螺杆菌感染?
Nihon Rinsho. 2001 Feb;59(2):319-22.
2
Evaluation of the PyloriTek test for detection of Helicobacter pylori infection in cases with and without eradication therapy.
Am J Gastroenterol. 1998 Nov;93(11):2102-5. doi: 10.1111/j.1572-0241.1998.00601.x.
3
Diagnosis of Helicobacter pylori infection. When to use which test and why.幽门螺杆菌感染的诊断。何时使用何种检测方法以及原因。
Scand J Gastroenterol Suppl. 1996;215:63-5.
4
Diagnostics of Helicobacter pylori infection in patients with peptic ulcer bleeding.消化性溃疡出血患者幽门螺杆菌感染的诊断
Z Gastroenterol. 2004 Feb;42(2):141-6. doi: 10.1055/s-2004-812836.
5
The effectiveness of (IgG-ELISA) serology as an alternative diagnostic method for detecting Helicobacter pylori infection in patients with gastro-intestinal bleeding due to gastro-duodenal ulcer.(IgG-ELISA)血清学作为检测因胃十二指肠溃疡导致胃肠道出血患者幽门螺杆菌感染的替代诊断方法的有效性。
Rev Esp Enferm Dig. 2002 Dec;94(12):725-36.
6
[Effects of different triple therapies on duodenal ulcer-associated Helicobacter pylori infection and a one-year follow-up study].[不同三联疗法对十二指肠溃疡相关幽门螺杆菌感染的影响及一年随访研究]
Zhonghua Yi Xue Za Zhi. 2004 Jul 17;84(14):1161-5.
7
Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients.重复呼气试验以确认幽门螺杆菌根除情况:419例患者的额外获益与成本
Aliment Pharmacol Ther. 2008 Dec 1;28(11-12):1304-8. doi: 10.1111/j.1365-2036.2008.03846.x. Epub 2008 Sep 4.
8
Helicobacter pylori infection in Turkish children: comparison of diagnostic tests, evaluation of eradication rate, and changes in symptoms after eradication.土耳其儿童幽门螺杆菌感染:诊断测试的比较、根除率评估及根除后症状变化
Helicobacter. 2004 Jun;9(3):242-8. doi: 10.1111/j.1083-4389.2004.00230.x.
9
Noninvasive tests as a substitute for histology in the diagnosis of Helicobacter pylori infection.非侵入性检测作为组织学的替代方法用于幽门螺杆菌感染的诊断。
Gastrointest Endosc. 2000 Jul;52(1):20-6. doi: 10.1067/mge.2000.106686.
10
Comparative accuracy of 3 monoclonal stool tests for diagnosis of Helicobacter pylori infection among patients with dyspepsia.比较 3 种单克隆粪便检测法在消化不良患者中诊断幽门螺杆菌感染的准确性。
Clin Infect Dis. 2010 Feb 1;50(3):323-8. doi: 10.1086/649860.